SCHEMBL4057283

SCHEMBL4057283

CC(C)(C)[Si](C)(C)OCC1C[CH]CC1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FKBP1A P62942 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5026052 0.86 MAPK1 (0.38) FKBP1A
SCHEMBL8062803 0.80 FKBP1A (0.33) FKBP1A
SCHEMBL12632024 0.80 FKBP1A (0.33) FKBP1A
SCHEMBL14363239 0.79 FKBP1A (0.32) FKBP1A
SCHEMBL15570492 0.78 DUT (0.31)
SCHEMBL5673208 0.76 FKBP1A (0.37) FKBP1A
SCHEMBL7739282 0.76 FKBP1A (0.34) FKBP1A
SCHEMBL7738017 0.75 CYP1A2 (0.35) FKBP1A
SCHEMBL7739318 0.75 CYP1A2 (0.35) FKBP1A
SCHEMBL7738582 0.75 CYP1A2 (0.35) FKBP1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009117540-A1 BRIDGED HETEROCYCLES AS HIV INTEGRASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-09-24 WO disclosed